CD34 and acute myeloid leukemia: More recently, SE analysis of AML patients has identified a novel subgroup with a strong SE in the RARα locus, resulting in a high level of RARα mRNA in leukemic cells, which accounted for approximately 25% of the samples analyzed and was not found in normal CD34-positive cells [8].